rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    DRMA
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Dermata receives federal trademark for Tome skincare brand
      14h agoInvesting.comDRMA
      Dermata Therapeutics earnings beat by $0.08, revenue was in line with estimates
      Nov 11Investing.comDRMA
      Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Third Quarter 2026

      - Dermata generates product revenue following the launch of its first commercial product,Tome™ Foundational Treatment,

      Nov 10USA TodayDRMA
      Dermata Therapeutics Highlights Media Recognition of Tome Skincare Following Commercial Launch
      Nov 5Yahoo FinanceDRMA
      Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial

      - Tome Clearing Treatment is Dermata's second once-weekly skincare product under its Tome brand -- Tome Clearing

      Oct 29USA TodayDRMA
      Why Is Dermata Therapeutics Stock Gaining Thursday?
      Oct 15BenzingaDRMADRMAW
      Dermatology Developer Surges 39% as Clinical Study Validates Skincare Product

      Real-time index price for TSX Venture Composite Index (JX), along with buy or sell indicators, analysis, charts, historical performance, news and more

      Oct 15The Globe and MailDRMADRMAW
      Dermata reports positive results from Tome skincare study
      Oct 15Investing.comDRMADRMAW
      Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
      Oct 15MorningstarDRMADRMAW
      12 Health Care Stocks Moving In Tuesday's After-Market Session
      Sep 8BenzingaDRMADRMAWINNV
      Dermata launches first direct-to-consumer skincare product
      Aug 25Investing.comDRMADRMAW
      Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment

      SAN DIEGO, CA / ACCESS Newswire / August 25, 2026 / Dermata Therapeutics, Inc. (Nasdaq:DRMA) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today announced the official commercial launch of the Tome Foundational Treatment, the first product available for purchase under the Company's Tome skincare brand. The Foundational Treatment is now available for immediate purchase at www.tomeskincare.com, either as a one-time purchase or through a monthly subscription at a discounted price. The commercial launch marks a significant landmark in Dermata's evolution into a direct-to-consumer skincare company and represents the Company's first commercial product under the Tome brand.

      Aug 25Yahoo FinanceDRMADRMAW
      Dermata opens preorders for Tome skincare product
      Aug 21Investing.comDRMADRMAW
      Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch

      - Preorders can be made by visiting www.tomeskincare.com - - Dermata is ready to begin shipping orders on the expected launch date of August 25, 2026 - - Tome Foundational Treatment is a once-weekly topical mask for skin renewal - SAN DIEGO, CA / ...

      Aug 21Yahoo FinanceDRMADRMAW

      This is the newest page. Registered accounts read further back.